Kim WJ - Search Results

1

Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.

Piao XM, Jeong P, Kim YH, Byun YJ, Xu Y, Kang HW, Ha YS, Kim WT, Lee JY, Woo SH, Kwon TG, Kim IY, Moon SK, Choi YH, Cha EJ, Yun SJ, Kim WJ. Piao XM, et al. Among authors: kim yh, kim iy, kim wj, kim wt. Int J Cancer. 2019 Jan 15;144(2):380-388. doi: 10.1002/ijc.31849. Epub 2018 Nov 13. Int J Cancer. 2019. PMID: 30183088

2

Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.

Kim IY, Lee DH, Lee DK, Kim WJ, Kim MM, Morton RA, Lerner SP, Kim SJ. Kim IY, et al. Among authors: kim mm, kim wj, kim sj. Cancer Res. 2004 Oct 15;64(20):7355-60. doi: 10.1158/0008-5472.CAN-04-0154. Cancer Res. 2004. PMID: 15492256

3

Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression.

Jeong P, Kim EJ, Kim EG, Byun SS, Kim CS, Kim WJ. Jeong P, et al. Among authors: kim cs, kim eg, kim wj, kim ej. Urology. 2004 Nov;64(5):1052-6. doi: 10.1016/j.urology.2004.06.018. Urology. 2004. PMID: 15533517

4

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.

Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun Wee J, Kim WJ. Kim EJ, et al. Among authors: kim wj, kim j. Urology. 2005 Jan;65(1):70-5. doi: 10.1016/j.urology.2004.08.005. Urology. 2005. PMID: 15667866

5

Genetic and epigenetic aspects of bladder cancer.

Kim WJ, Quan C. Kim WJ, et al. J Cell Biochem. 2005 May 1;95(1):24-33. doi: 10.1002/jcb.20412. J Cell Biochem. 2005. PMID: 15759278 Review.

6

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, Li QL, Yang JO, Ito Y, Bae SC. Kim WJ, et al. Among authors: kim ej, kim j. Cancer Res. 2005 Oct 15;65(20):9347-54. doi: 10.1158/0008-5472.CAN-05-1647. Cancer Res. 2005. PMID: 16230397

7

Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer.

Quan C, Cha EJ, Lee HL, Han KH, Lee KM, Kim WJ. Quan C, et al. Among authors: kim wj. J Urol. 2006 Apr;175(4):1512-6. doi: 10.1016/S0022-5347(05)00659-2. J Urol. 2006. PMID: 16516038

8

Aqueous extract of Magnolia officinalis mediates proliferative capacity, p21WAF1 expression and TNF-alpha-induced NF-kappaB activity in human urinary bladder cancer 5637 cells; involvement of p38 MAP kinase.

Lee SJ, Kim HM, Cho YH, Park K, Kim EJ, Jung KH, Kim CH, Kim WJ, Moon SK. Lee SJ, et al. Among authors: kim wj, kim hm, kim ej, kim ch. Oncol Rep. 2007 Sep;18(3):729-36. Oncol Rep. 2007. PMID: 17671727

9

Cancer gene therapy using adeno-associated virus vectors.

Park K, Kim WJ, Cho YH, Lee YI, Lee H, Jeong S, Cho ES, Chang SI, Moon SK, Kang BS, Kim YJ, Cho SH. Park K, et al. Among authors: kim yj, kim wj. Front Biosci. 2008 Jan 1;13:2653-9. doi: 10.2741/2872. Front Biosci. 2008. PMID: 17981740 Review.

10

Sanguinarine-induced G1-phase arrest of the cell cycle results from increased p27KIP1 expression mediated via activation of the Ras/ERK signaling pathway in vascular smooth muscle cells.

Lee B, Lee SJ, Park SS, Kim SK, Kim SR, Jung JH, Kim WJ, Moon SK. Lee B, et al. Among authors: kim sr, kim wj, kim sk. Arch Biochem Biophys. 2008 Mar 15;471(2):224-31. doi: 10.1016/j.abb.2008.01.008. Epub 2008 Jan 19. Arch Biochem Biophys. 2008. PMID: 18237541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,103 results

Search Page

Filters